Multiple endocrine neoplasia type 1 (MEN-1) 
Introduction
The MEN1 gene is mutated in the germ line of patients with multiple endocrine neoplasia type 1 (MEN-1). The clinical manifestation of MEN-1 is characterized by pituitary and parathyroid hyperplasias and adenomas, neuroendocrine tumors of the gut, and carcinoids of the lung (1); the disease occurs either sporadically or as a familial trait with an autosomal dominant mode of inheritance (2) . Germ line mutations in the MEN1 gene have been described in familial and sporadic MEN-1 patients (3) (4) (5) (6) . Somatic mutations in MEN1 are seen in a variety of MEN-1 -related tumors (7) (8) (9) . The mutations are typically missense, frameshift, or truncation mutations within the open-reading frame, with no mutational hotspots. The second, wild-type allele is lost in tumors from these patients.
The MEN1 gene is thus proposed to function as a tumorsuppressor gene, as inferred from the frequent allelic loss in MEN-1 -associated tumors (10) . Mouse genetic experiments, combined with human genetic data, support the conclusion that MEN1 is a tumor-suppressor gene. Heterozygous MEN1 knockout mice develop multiple endocrine tumors similar to those found in human MEN-1 patients, whereas homozygous deletion is embryonic lethal (11) (12) (13) . Furthermore, disruption of the MEN1 gene in pancreatic islet h cells has been shown to result in tumor development (14, 15) .
The amino acid sequence of the menin protein, which exhibits no sequence similarity with any other known proteins, is highly conserved; orthologues have been identified in vertebrates and Drosophila (16) (17) (18) (19) (20) , but not in the genomes of yeast or Caenorhabditis elegans. The 610-amino-acid sequence of menin exhibits no identifiable functional motifs, except for two novel and independent carboxyl-terminal nuclear localization signals (21) , consistent with its predominantly nuclear distribution (21, 22) . Despite the limited tumor spectrum for MEN1 mutations, menin is ubiquitously expressed (23) and is likely to have a universal function. A number of studies revealed that menin interacts with a variety of proteins and may play a significant role in transcriptional regulation. Menin has been proposed to be both an activator and a repressor of transcription. The human MEN1 gene was found to directly repress telomerase expression (24) . The activator protein-1 transcription factor JunD, nuclear factor-nB, nm23, Pem, Smad-3, replication protein A, and FANCD2 have all variously been reported to interact with menin (for review, see ref. 25) .
We have previously proposed that one mechanism of action of menin is transcriptional activation or repression of target genes by epigenetic regulation, through the methylation of histone subunits on lysine residues. We determined that menin associates with a histone methyltransferase (HMTase) complex containing MLL2, a homologue of mixed lineage leukemia (MLL), as well as other mammalian homologues of the yeast SET1 complex. The menin-associated complex specifically methylates histone H3 on lysine 4, an epigenetic mark typically associated with transcriptionally active chromatin (26) . We noted that MEN1 knockout embryos and cells show decreased expression of the homeobox genes Hoxc6 and Hoxc8, and that menin binds directly to the Hoxc8 locus. Menin has also been shown to interact with the proto-oncoprotein MLL in an HMTase complex similar to the MLL2-menin complex (27) , and was found to be an essential component of this complex in the maintenance of HoxA9 gene expression by wild-type MLL.
The MLL-menin interaction is essential for MLL-dependent leukemogenesis (28, 29) . We subsequently extended the area of known menin-regulated genes by demonstrating that menin interacts with MLL to cooperatively regulate the expression of the cyclin-dependent kinase inhibitors p27
Kip1 and p18 Ink (30) . Furthermore, we determined that the menin-dependent methylation of H3 Lys-4 is crucial in islet tumor suppression, as this maintains the in vivo expression of p27 Kip1 and p18 Ink4c to prevent pancreatic islet tumors (31) .
Recently, a genome-wide analysis of menin binding suggested that this protein can target a broad range of promoters in multiple tissues, both in concert with, and independently of, the HMTase complex. The authors also postulated that menin may function as a corepressor of tissue-specific genes that promote cell growth, such as HLXB9, and that this activity may contribute to the bias in endocrine tumor formation in MEN1 (32) . Overall, these findings implicate menin in the regulation of both cell differentiation and cell cycle regulation, as well as global transcriptional regulation.
In a previous report (26) , we mentioned that menin migrates as a doublet on SDS-PAGE gels, indicating a possible posttranslational modification. We decided to investigate this phenomenon further, to determine the modifications that menin undergoes in vivo. Reversible protein phosphorylation, principally on serine, threonine, or tyrosine residues, is one of the most important and well-studied posttranslational modifications, and plays a critical role in the regulation of many cellular processes, including cell cycle, growth, apoptosis, and signal transduction pathways. For many proteins, multiple posttranslational modifications, such as phosphorylation, ubiquitination, and acetylation, may occur simultaneously or sequentially, and these modifications are crucial in the regulation of protein activity. The close relationship between altered posttranslational modifications in mammalian cells and developmental diseases and cancer has been well documented. In this study, we determined that menin is phosphorylated on two serine residues, Ser 543 and Ser 583 . Mutation of these residues had no effect on either the association of menin with trithorax family complex proteins Ash2L, Rbbp5, and MLL2, or on its histone methyltransferase activity. Similarly, binding of menin to the Hoxc8 locus was unaffected. Posttranslational modifications of menin may play an as yet undetermined role in the regulation of its function as a tumor suppressor.
Results

Menin Is Phosphorylated on Multiple Serine Residues
It was previously noted by our group that menin appeared on SDS-PAGE as a doublet (26) . To examine the mobility of menin in detail, we transfected wild-type MEN1 cDNA into 293T cells. Cell lysates were subjected to immunoprecipitation and immunoblotting with anti-menin antibody directed against the COOH terminus. As can be seen in Fig. 1A , endogenous menin migrates as a doublet, with one form migrating slower than the other (top, lane 1). The difference in migration appears to be 1 to 2 kDa, a size difference consistent with phosphorylation. Investigation of transfected menin (and overexposed Western blots of endogenous menin) revealed that the protein actually migrates as two doublets (top, lane 2; bottom).
The smaller form of menin in each doublet is predominant, and the larger set of doublets is more abundant than the smaller. The apparent molecular weight difference between the doublets was estimated at 5 to 10 kDa. Western blotting using anti-menin antibody generated against the NH 2 -terminal region (data not shown) revealed that the different isoforms could be seen with antibodies against both termini, in endogenous and transfected menin, and were therefore not due to splice variations as the transfected cDNA does not require splicing.
To determine if menin is phosphorylated, 293T cells untransfected or transfected with menin were phosphate starved for 1 hour and radiolabeled for 3 hours with [ 32 P]P i . Cell lysates were subsequently immunoprecipitated with anti-menin antibody, and radiolabeled protein was detected by autoradiography; samples run in parallel were blotted with anti-menin antibody. Phosphorylation of menin is detectable in both transfected (Fig. 1B, 4) .
To confirm that the mobility shift on immunoblots corresponded to menin phosphorylation, radiolabeled anti-menin immunoprecipitates and peptide-blocked control samples were treated with phosphatase enzyme. Phosphorylated menin could be detected in untreated immunoprecipitates, but not in samples treated with phosphatase (Fig. 1C) . To detect specifically which residues (Ser/Thr or Tyr) are phosphorylated, cells were subjected to phosphoamino acid analysis by metabolic labeling with [ 32 P]P i , immunoprecipitation of menin followed by SDS-PAGE separation, and autoradiography. The appropriate band was excised from the gel, digested, and separated using two-dimensional electrophoresis. Labeled phosphoamino acids were detected by autoradiography and identified by comigration with commercial standards. Phosphoamino acid labeling of menin showed exclusive serine phosphorylation (Fig. 1D) .
To determine precisely which serine residues are subject to phosphorylation, whole cell lysates of menin-transfected or untransfected 293T cells were immunoprecipitated with antimenin antibody and samples were separated on SDS-PAGE. Bands of interest were excised and analyzed by mass spectrometry. As expected, the protein was identified as menin, represented by peptide fragments covering 87.5% of the predicted sequence. We identified S543 as the most prevalent phosphopeptide of endogenous and overexpressed menin, and thus likely to be the major phosphorylation site (under the conditions investigated in this study); an additional phosphorylation site, S583, was mapped using transfected menin (Table 1) . Of the 39 serines in menin, 34 were represented by at least one peptide and 5 were not represented; 15 were represented by at least 4 peptides. Thus, we do not exclude the possibility of other serine phosphorylations and indeed we do detect residual phosphorylation of the S543A/S583A double mutant (see below).
To examine whether our coverage of menin phosphopeptides by mass spectrometric analysis was sufficient to identify all phosphorylation sites of the protein, stable MEN1 À/À MEFs harboring vector and either wild-type menin with serine to alanine mutations (see below) at S543 and S583 were examined. Cells were phosphate-starved, radiolabeled with inorganic 33 P, and immunoprecipitated with anti-menin antibody. Autoradiography of SDS-PAGE fractionated proteins revealed that menin is phosphorylated on residues in addition to those detected by mass spectrometry (data not shown). We wished to assess the role(s) played by the phosphorylated serine residues. We used site-directed mutagenesis to convert S543 and S583 to either glutamate, which mimics the ''constitutively on'' phosphorylation state (33) , or alanine, which acts as an unphosphorylated and unphosphorylatable residue. Transiently transfected 293T cells and stable cell lines derived from MEN1 À/À MEFs harboring vector and mutated menin (one of six mutants with substitutions at either or both of the serine residues under investigation-see Materials and Methods) were established, and associated HMTase activity was assayed. We immunoprecipitated with anti-menin antibody, analyzed a fraction for menin by immunoblotting, and did HMTase assays on a second portion. As can be seen in the Fig. 2A (bottom), menin and the described mutants are expressed and can be immunoprecipitated from extracts of all the cells except the KO + pBABE cells. Reconstitution of MEN1 À/À cells with wild-type menin, or any of the mutant forms examined, restored the association of HMTase activity with anti-menin immunoprecipitates ( Fig. 2A, top) . Next, we determined whether the phosphorylation state of either of the serine residues had an effect on the binding of menin to its associated complex members. Wild-type and mutant MEN1
À/À cells (described above) were lysed, immunoprecipitated with anti-menin antibody, and blotted with antimenin, anti-Ash2L, or anti-Rbbp5 antibodies. As can be seen in Fig. 2B Endogenous menin (top, lane 1) and transfected menin (top, lane 2 ) were immunoprecipitated from 293T cells and blotted using anti-menin antibody. Two sets of doublets can be identified; the mobility shift between doublets is f1 to 2 kDa and between sets is f8 to 10 kDa. Arrows, menin isoforms. The slowermigrating set of doublets of transfected menin can be observed using a shorter exposure MEFs. Quantitative real-time reverse transcription-PCR showed that mutation of the phosphorylation sites of menin had no significant effect on either Hoxc6 or Hoxc8 mRNA levels relative to that of h-actin (data not shown). We subsequently did chromatin immunoprecipitation assays on wild-type and mutant MEFs using anti-menin antibody. Immunoprecipitated DNA was subjected to quantitative real-time PCR using a probe to a region f200 bp upstream of Hoxc8 (c8P2) as previously described (26) , and a Gapdh control. No significant differences were observed in the binding of the mutant menin forms to the Hoxc8 locus, compared with wild-type menin (data not shown).
Menin Isoforms Are Unaltered by Proteasomal Degradation, the DNA Damage Response, and Cellular Differentiation
Menin reportedly interacts with a wide variety of transcriptional proteins, and has been implicated in DNA replication and repair (24, 34, 35) . We investigated whether menin isoforms were altered during DNA damage response. Wild-type MEFs were treated with 1,500-rad g irradiation; lysed supernatant samples taken at various time intervals (see Materials and Methods) were separated on SDS-PAGE and blotted with antimenin antibody. No differences in menin isoforms were observed under the conditions examined (Fig. 3A) . We also treated MEF wild-type cells with the proteasome inhibitor MG132 (see Materials and Methods); there was no significant change in either the amount or the phosphorylation state of Ser 543 and/or Ser 583 of wild-type menin present under the conditions used in this study (data not shown), indicating that the phosphorylation of menin at these two serine residues likely serves an alternative purpose than targeting menin into the degradation pathway. To determine if menin expression or phosphorylation correlated with morphologic differentiation, HL60 cells were treated with the inducers all-trans retinoic acid or 12-O-tetradecanoylphorbol-13-acetate, which stimulate differentiation into granulocytes and macrophages, respectively. No differences in menin isoforms were observed for any of the cellular differentiation states examined (Fig. 3B) .
Menin Phosphorylation on Ser 543 and Ser 583 Does Not Impact Subcellular Localization or Cell Cycle Status
Phosphorylation can play a role in both the DNA damage response and subcellular localization of proteins. The two phosphorylation sites determined in this study are situated between the two nuclear localization signals located at the COOH terminus of menin, so it was hypothesized that phosphorylation at these serine residues may play a role in subcellular localization. We determined the subcellular localization of menin isoforms by cellular fractionation; wild-type and mutant menin re-expressed in MEN1 À/À cells was divided into nuclear and cytoplasmic fractions following exposure to mitomycin C, and compared with untreated fractions. All isoforms were extracted with the nuclear fraction in each case (Fig. 3C) (Fig. 3D) .
Discussion
Posttranslational Modifications of Menin
Menin loss of function plays a significant role in human neoplasms of multiple endocrine organs (1). Despite extensive genetic and biochemical studies, the biological functions of menin remain unclear. Protein function is often under the tight regulation of posttranslational modifications such as phosphorylation. Altered protein modifications in mammalian cells are closely related to developmental diseases and cancer. As a tumor suppressor, menin may be involved in a signal 
NOTE: The number of identified phosphopeptides is indicated in parentheses.
MacConaill et al.
Mol Cancer Res 2006;4(10). October 2006
transduction cascade, potentially regulating cell growth or differentiation; however, none of the upstream regulators of menin phosphorylation have been identified, and the signal transduction pathway of menin remains to be elucidated. In this study, we investigated the regulation of menin at the cellular level by posttranslational modification. We established that menin is phosphorylated; the major phosphorylation site is S543, and phosphorylation also occurs on S583. Other serine residues of menin are also subject to phosphorylation, as the double alanine substitution mutant of both sites is still phosphorylated, although the identity and significance of additional phosphorylation sites remains to be investigated. Menin has been shown to be an essential component of both the MLL and MLL2 complexes involved in histone methyltransferase activity and epigenetic regulation. Complexes associated with several tumor-derived menin mutants lack histone methyltransferase activity, suggesting that this activity is related to the tumor-suppressor function of menin. Menin is also essential for the transcriptional activation of p27
Kip1 and p18
Ink4c ; loss of function results in deregulated cell growth. Furthermore, menin is required for maintenance of Hox gene expression, and thus the cellular differentiation of higher eukaryotes. These findings underscore the importance of the menin-MLL histone methyltransferases in development and disease. Neither abrogation nor constitutive expression of the two serine residues examined in this study affects binding of menin to its trithorax family proteins, MLL2, Rbbp5, and Ash2L, or the associated histone methyltransferase activity. Neither does mutation of the phosphorylation sites interfere with the binding of menin to RNA polymerase II. Mutation of either or both serine residues did not alter the expression of Hoxc6 and Hoxc8 mRNA, and does not affect binding of the menin protein to the Hoxc8 locus. In addition, we did not see any effect of DNA damage or cell differentiation on wild-type menin isoforms. Mutation of Ser 543 or Ser 583 to either alanine or glutamate had no effect on the subcellular localization of menin; neither did mutation of these residues affect cell cycle status under the conditions examined in this study.
Although we were not able to determine the role of the Ser 543 and Ser 583 phosphorylations identified in this study, these modifications may play a role in the regulation of menin as a tumor-suppressor protein, and future studies should result in the elucidation of their exact function. Furthermore, we anticipate that further study may uncover additional modifications of menin. First, we know that there are additional as yet unidentified phosphorylation sites; second, there may be additional forms of posttranslational modification. The means by which posttranslational modification can modulate menin function remain to be determined by future studies. It is probable that the biological functions of menin are broad and pleiotropic; however, further investigation of the signal transduction cascades in which menin is involved, and regulated by, may lead to novel gene therapy targets in the treatment of this disease. 
Materials and Methods
Plasmids and Recombinant Retroviruses
Mutations in the MEN1 gene were generated using a QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) with primers from Invitrogen (for primer sequences, see Table 2 ). Fragments were digested with EcoRI and inserted into pcDNA3 expression vector (Invitrogen). Orientation of inserts was determined by PCR, and mutations were verified by automated DNA sequencing of the entire MEN1 cDNA. To generate retroviral expression vectors, the verified menin/ pcDNA3 constructs were digested and inserted into appropriately digested pBABE-Hygro plasmid. Recombinant retroviruses were produced in 293T cells transiently transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA).
Cell Culture, Manipulations, Infections, and Fractionation
Human embryonic kidney cells (293T cells) and HL60 cells were obtained from American Type Culture Collection (Manassas, VA), and MEN1
+/+ and MEN1 À/À immortalized mouse embryo fibroblasts (MEF) were established in the laboratories of X. Hua as described (34) . HL60 cells were maintained in Iscove's modified Dulbecco's medium containing 20% FCS (Gemini, Woodland, CA). Other cell lines were maintained in DMEM, supplemented with 10% FCS, plus penicillin and streptomycin. To generate MEN1 À/À MEFs stably expressing recombinant human menin and mutants, cells were infected with the corresponding recombinant retroviruses: pBABE-Hygro alone, pBABE-Hygro-MEN1, or pBABEHygro expressing one of the six MEN1 mutants (S543A; S543E; S583A, S583E, S543AS583A; and S543ES583E). Infected cell lines were selected with hygromycin at 200 Ag/ mL for 1 week. Nuclear and cytoplasmic fractions were isolated using a NE-PER kit (Pierce, Rockford, IL).
Antibodies
Anti-menin, anti-Ash2 (C19), and anti-Rbbp5 antibodies are rabbit polyclonal antibodies made by Bethyl Laboratories (Montgomery, TX) as previously described (26). RNA were used for the immunoprecipitations. Antibody dilutions used for each immunoprecipitation were as previously described (26) . For in vitro phosphatase experiments, 100 Ag cell extract were incubated for 15 minutes at 30jC with 100 units of E protein phosphatase (NEB, Ipswich, MA) in buffer. Following four washes with PBS, the immunoprecipitates were separated by SDS-PAGE and transferred to nitrocellulose membrane (Schleicher & Schuell, Keene, NH). Membranes were blotted with appropriate antibody and signals were observed using the ECL Plus Western blotting detection system (Amersham Biosciences). For mass spectrometry, immunoprecipitates were fractionated on 8% gels and stained with Coomassie blue. Bands of interest were excised and digested with trypsin, chymotrypsin, or elastase. Mass spectrometry was done at the Taplin Biological Mass Spectrometry Facility as previously described (36) , using a Finnigan LTQ linear ion-trap mass spectrometer (Thermo Electron, San Jose, CA).
Phosphate Labeling
293T cells, MEN1 À/À MEFs, and derivative MEF cell lines were washed with PBS and phosphate starved by incubation for 1 hour in DMEM lacking sodium phosphate (Life Technologies, Gaithersburg, MD). Cells were labeled by the addition of 3 mCi of 32 P[P i ] or 33 P[P i ] (Perkin-Elmer Life Sciences, Boston, MA) per plate for 3 hours. Menin was subsequently immunoprecipitated from detergent-solubilized lysates as described above. Immunoprecipitates were fractionated on 15% SDS-PAGE gels and dried, and radiolabeled proteins were detected by autoradiography.
Phosphoamino Acid Labeling
Two-dimensional phosphoamino acid analysis was conducted by excising the appropriate 32 P-labeled band from the polyvinylidene difluoride membrane, followed by hydrolysis of the sample in 6 N HCl for 2 hours at 100jC. Samples were dried; resuspended in buffer containing phosphotyrosine, phosphothreonine, and phosphoserine standards; and loaded onto cellulose thin-layer plates (Merck, Whitehouse Station, NJ). Two-dimensional electrophoresis was done at pH 1.9 in the first dimension and pH 3.5 in the second dimension (37, 38) . The plates were then dried, sprayed with 0.25% (w/v) ninhydrin in acetone, and baked at 65jC for 20 minutes. Phosphoamino acids were visualized by autoradiography and compared with localization of unlabeled standards.
Histone Methyltransferase Assays
The histone methyltransferase assay was done as previously described (26, 39) . Assay buffer and core histones were obtained from the HMT Assay Reagent kit (Upstate Biotechnology, Lake Placid, NY). Laemmli sample buffer was added to 1Â concentration [2% SDS, 10% glycerol, 100 mmol/L DTT, 60 mmol/L Tris (pH 6.8), and 0.001% bromophenol blue], and samples were boiled for 5 minutes, fractionated on 15% SDS-PAGE, and stained with Coomassie blue. The gel was then amplified 30 minutes (Amplify, Amersham Biosciences), dried, and exposed to film.
Proteasome Inhibition and Stimulation of DNA Damage Response MEN1 +/+ MEFs were treated with 20 Ag cyclohexamide/mL to prevent further protein synthesis, and incubated in the absence or presence of the proteasome inhibitor MG132 (final concentration, 25 Amol/L; Sigma, St. Louis, MO). Whole cell extracts were prepared from samples taken at different time points between 0 and 8 hours, and the relative quantities of menin variants were examined by Western blotting using antimenin antibody.
To determine whether menin forms were altered during DNA damage response, wild-type MEFs were treated with 1,500-rad g irradiation, delivered using a Gammacell 40 apparatus. At time intervals between 0 and 5 hours, lysed supernatant fractions were isolated, separated on SDS-PAGE, and blotted with antimenin antibody. For mitomycin C treatment, cells were continuously exposed to the drug (150 ng/AL) for the indicated time as previously described (40) .
Cell Synchronization and Cell Differentiation
MEF MEN1 À/À derivative cell lines transfected with vector alone, or wild-type or mutant menin were washed twice with serum-free medium followed by either serum starvation (0.5% serum, 48 hours), or treatment with one of the following drugs: nocodazole, 0.04 Ag/mL for 16 hours; mimosine, 400 Amol/L for 16 hours; and hydroxyurea, 0.5 mmol/L for 24 hours. At the time points indicated, cell lysates were immunoblotted with anti-menin antibody. Cell cycle arrest in the appropriate phase was confirmed by fluorescence-activated cell sorting analysis of propidium iodide -stained cells (41) . For the analysis of changes in posttranslational modifications of menin during cell Real-time Quantitative PCR Analysis of Hox Gene Expression First-strand cDNA was synthesized from total RNA (1 Ag) using an oligo(dT) primer and BD Sprint PowerScript PrePrimed SingleShot reaction tubes (BD Biosciences). Reaction products were diluted in Tris-EDTA buffer, and real-time PCR quantification of Hoxc6, Hoxc8, and human MEN1 and mouse MEN1 gene expression was done in triplicate using BD Biosciences probes. Results were analyzed using a standard curve and the relative quantitation method as described in ABI User Bulletin 2. h-Actin was used as an internal reference standard. BD Biosciences probe sequences are available on request.
Chromatin Immunoprecipitation
Chromatin immunoprecipitations were done using the Chromatin Immunoprecipitation Assay kit (Upstate Biotechnology). Real-time PCR quantification of chromatin immunoprecipitation was done in triplicate using Taqman probes and an ABI Prism 7700 instrument (Applied Biosystems). Menin chromatin immunoprecipitations were quantified relative to inputs as described (42) . Hoxc8 genomic Taqman probe sequence (P2) is AACACCTTCAAACTAGAGTGCACACCT-TGGA. Primer sequences are available upon request.
